Centerville, Ohio 45459

  • Osteoarthritis Thumb

Purpose:

Single blinded PRP vs. Corticosteroid vs. Placebo (normal saline) intra-articular injection for basal joint arthritis.


Criteria:

Inclusion Criteria: - Stage 1-3 osteoarthritis of the basal joint Exclusion Criteria: - Patients with Stage 4 1st carpometacarpal joint arthritis as described by Eaton - Patients who have received a corticosteroid injection in the last year to the 1st CMC joint on the proposed study side - Patients who have scaphotriquetral, radioscaphoid, or scaphotrapezial osteoarthritis - Patients who have concurrent DeQuervain's tenosynovitis or intersection syndrome or have been treated for either of these in the last 3 months - Patients undergoing evaluation of cervical radiculopathy - Patients with fibromyalgia or inflammatory rheumatic disease - Patients with Pressier disease, Kienbock's, or avascular necrosis of the scaphoid - Patients with any history of primary or secondary bone tumor - Patients that are pregnant or terminally ill


NCT ID:

NCT03196310


Primary Contact:

Jesse A. Raszewski, DO
Phone: 4128184923
Email: jesse.raszewski@gmail.com


Backup Contact:

N/A


Location Contact:

Centerville, Ohio 45459
United States

Laura Peterson
Phone: 800-824-9861
Email: lpeterson@oaswo.com

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: December 07, 2022

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.